JPH11225796A5 - - Google Patents

Info

Publication number
JPH11225796A5
JPH11225796A5 JP1998315511A JP31551198A JPH11225796A5 JP H11225796 A5 JPH11225796 A5 JP H11225796A5 JP 1998315511 A JP1998315511 A JP 1998315511A JP 31551198 A JP31551198 A JP 31551198A JP H11225796 A5 JPH11225796 A5 JP H11225796A5
Authority
JP
Japan
Prior art keywords
thrombomodulin
sample
thrombin
protein
reagent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP1998315511A
Other languages
English (en)
Japanese (ja)
Other versions
JPH11225796A (ja
JP4361980B2 (ja
Filing date
Publication date
Priority claimed from DE19749197A external-priority patent/DE19749197A1/de
Application filed filed Critical
Publication of JPH11225796A publication Critical patent/JPH11225796A/ja
Publication of JPH11225796A5 publication Critical patent/JPH11225796A5/ja
Application granted granted Critical
Publication of JP4361980B2 publication Critical patent/JP4361980B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP31551198A 1997-11-07 1998-11-06 サンプルの潜在的抗血液凝固能の測定法 Expired - Fee Related JP4361980B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19749197:9 1997-11-07
DE19749197A DE19749197A1 (de) 1997-11-07 1997-11-07 Verfahren zur Bestimmung des antikoagulatorischen Potentials einer Probe

Publications (3)

Publication Number Publication Date
JPH11225796A JPH11225796A (ja) 1999-08-24
JPH11225796A5 true JPH11225796A5 (cg-RX-API-DMAC7.html) 2005-12-08
JP4361980B2 JP4361980B2 (ja) 2009-11-11

Family

ID=7847900

Family Applications (1)

Application Number Title Priority Date Filing Date
JP31551198A Expired - Fee Related JP4361980B2 (ja) 1997-11-07 1998-11-06 サンプルの潜在的抗血液凝固能の測定法

Country Status (8)

Country Link
US (2) US20020019021A1 (cg-RX-API-DMAC7.html)
EP (1) EP0915340B1 (cg-RX-API-DMAC7.html)
JP (1) JP4361980B2 (cg-RX-API-DMAC7.html)
AT (1) ATE315233T1 (cg-RX-API-DMAC7.html)
AU (1) AU751525B2 (cg-RX-API-DMAC7.html)
CA (1) CA2252983C (cg-RX-API-DMAC7.html)
DE (2) DE19749197A1 (cg-RX-API-DMAC7.html)
ES (1) ES2255121T3 (cg-RX-API-DMAC7.html)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT947585E (pt) * 1998-03-19 2001-11-30 Instrumentation Lab Spa Metodo in vitro melhorado, kits e reagentes para a peaquisa de defeitos de coagulacao sanguinea
WO2001098782A1 (fr) * 2000-06-22 2001-12-27 Mochida Pharmaceutical Co., Ltd Kit de determination du pouvoir de coagulation du sang
US6432658B1 (en) * 2000-09-13 2002-08-13 Affinity Biologicals, Inc. Method for measuring antithrombin activity
US6448024B1 (en) 2000-10-03 2002-09-10 Roche Diagnostics Corporation Method, reagent, cartridge, and device for determining fibrinogen
US6645768B1 (en) 2000-10-27 2003-11-11 Biomerieux, Inc. Reagent and kit for determining global coagulability and hemostatic potential
US6743596B1 (en) * 2000-10-27 2004-06-01 Biomerieux, Inc. Method of determining global coagulability hemostatic potential
EP1367135A1 (en) * 2002-05-29 2003-12-03 Pentapharm AG Improved method for the assessment of thrombin formation in blood or plasma
ES2390271T3 (es) * 2003-09-22 2012-11-08 University Of North Carolina At Chapel Hill Fosfolípidos solubles para uso en ensayos de factores de coagulación
US20050221414A1 (en) * 2004-03-31 2005-10-06 Katalin Varadi Kit for measuring the thrombin generation in a sample of a patient's blood or plasma
US7148067B2 (en) * 2004-08-31 2006-12-12 The Board Of Trustees Of The University Of Illinois Thromboplastin reagents
EP1853926A2 (en) * 2005-02-16 2007-11-14 The Board Of Trustees Of The University Of Illinois Procoagulants based on metal-chelating lipids
CN101184775A (zh) * 2005-03-04 2008-05-21 伊利诺斯大学理事会 凝血及纤溶级联系统的调控剂
GB2433592A (en) * 2005-12-23 2007-06-27 Pentapharm Ag Assay for thrombin inhibitors
US8821861B2 (en) 2007-10-05 2014-09-02 The Board Of Trustees Of The University Of Illinois Fibrin sealant
WO2009061697A1 (en) 2007-11-09 2009-05-14 The Board Of Trustees Of The University Of Illinois Anticoagulant antagonist and hemophilia procoagulant
JP2009198506A (ja) * 2009-04-10 2009-09-03 Shino Test Corp 血液凝固反応抑制血漿タンパク質の活性測定方法及び活性測定試薬
CA2811822C (en) * 2010-09-20 2019-12-03 The University Of Queensland Serum preparation
JP5818299B2 (ja) * 2010-12-27 2015-11-18 国立大学法人名古屋大学 凝固因子として作用する異常トロンビンのためのトロンビン不活化動態測定方法
JP5640189B2 (ja) * 2011-06-17 2014-12-17 学校法人東日本学園 ループスアンチコアグラント検出用血液凝固時間の測定方法
WO2014020183A1 (de) 2012-08-03 2014-02-06 Ici Immunochemical Intelligence Gmbh In-vitro-assay zur diagnose von störungen der hämostase
CN104374621A (zh) * 2014-11-03 2015-02-25 温州市倍可特医疗器械有限公司 用于血液采集容器的血液促凝剂及其制备方法和应用
US10809393B2 (en) * 2015-04-23 2020-10-20 Fermi Research Alliance, Llc Monocrystal-based microchannel plate image intensifier
EP3779379B1 (en) 2018-04-04 2025-02-12 Mitsubishi Electric Corporation Infrared solid-state imaging device
JPWO2022145477A1 (cg-RX-API-DMAC7.html) * 2020-12-28 2022-07-07
CN115219292B (zh) * 2022-06-09 2025-09-30 常熟常江生物技术有限公司 全自动血栓弹力图仪质控品及其制备方法、应用方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5221614A (en) * 1988-03-03 1993-06-22 Nippon Shoji Kabushiki Kaisha Method and reagent for determining the biological activity of antithrombin III by measuring coagulation time
US5202421A (en) * 1988-12-27 1993-04-13 Mochida Pharmaceutical Co., Ltd. Anticoagulant substance obtained from urine and process for the preparation thereof
US5486599A (en) * 1989-03-29 1996-01-23 The Board Of Trustees Of The Leland Stanford Junior University Construction and use of synthetic constructs encoding syndecan
US6063763A (en) * 1989-04-28 2000-05-16 Schering Aktiengesellschaft Protease-resistant thrombomodulin analogs
US5051357A (en) * 1989-07-14 1991-09-24 Board Of Trustees Operating Michigan State University Method and assay using inactivation of factors Va and VIIIa by activated Protein C to diagnose thrombic disease or assay for Protein C and kit therefor
AU6403590A (en) * 1989-09-25 1991-04-18 Asahi Kasei Kogyo Kabushiki Kaisha Isolated, physiologically active human thrombomodulin polypeptide
EP0544826B1 (en) * 1990-08-15 2002-01-02 Paion GmbH Superior thrombomodulin analogs for pharmaceutical use
US5273962A (en) * 1990-11-30 1993-12-28 Kowa Co., Ltd. Human urinary thrombomodulin with a modified glycosaminoglycan (GAG) binding site
IL100093A0 (en) * 1990-11-30 1992-08-18 Kowa Co Thrombin-binding substance and process for preparing the same
AU2870992A (en) * 1991-10-04 1993-05-03 Board Of Regents Of The University Of Nebraska, The A soluble thrombomodulin-based one-stage assay for vitamin k-dependent coagulation-inhibiting proteins
SE470274B (sv) * 1991-11-13 1993-12-20 Bjoern Dahlbaeck Användning av en in vitro-metod för diagnos av blodkoagulationssjukdomar
FR2689640B1 (fr) * 1992-04-06 1997-08-08 Bio Merieux Procede pour la determination d'une activite proteine c et/ou proteine s dans un echantillon plasmatique.
DE4229933A1 (de) * 1992-09-08 1994-03-10 Max Planck Gesellschaft Verfahren zur Bestimmung von Thrombose verursachenden Lupus-anticoagulant-Antikörpern
DE4427785A1 (de) * 1994-08-08 1996-02-15 Behringwerke Ag Verfahren zum Nachweis von Störungen des Protein C/Protein S-Systems
ES2154703T5 (es) * 1994-11-10 2008-02-01 Dade Behring Marburg Gmbh Procedimiento para la deteccion especifica de un factor de coagulacion v activado con una estabilidad elevada frente a proteina c activada.

Similar Documents

Publication Publication Date Title
JPH11225796A5 (cg-RX-API-DMAC7.html)
CA2252983A1 (en) Method for determining the anticoagulatory potential of a sample
EP0420332B1 (en) Method for determining the endogenous thrombin potential of plasma and blood, and also a kit for use in said method
US5051357A (en) Method and assay using inactivation of factors Va and VIIIa by activated Protein C to diagnose thrombic disease or assay for Protein C and kit therefor
US6994984B2 (en) Hematological assay
US5266462A (en) Measurement of platelet activities
US5780255A (en) Protein C pathway screening test
Ząbczyk et al. Assays of fibrin network properties altered by VKAs in atrial fibrillation–importance of using an appropriate coagulation trigger
US5726028A (en) Method for detecting disturbances of the protein c/protein s system
Jackson et al. A critical evaluation of the prothrombin time for monitoring oral anticoagulant therapy
JPH08220091A (ja) 活性化状態の活性化タンパク質ｃに対する安定性が増大された凝固ｖ因子を特異的に検出する方法
US20060234325A1 (en) Hematological assay and kit
Francis Jr A simplified PTT-based protein C activity assay using the thrombin-thrombomodulin complex
US5753510A (en) Calibrator for use in test methods for detecting a defective coagulation factor V
US5529905A (en) Method of assaying plasma proteins with prothrombin fragments
AU729843B2 (en) Method for the functional detection of disorders in the protein C system
Mohri et al. Abnormalities in the protein C anticoagulant pathway detected by a novel assay using human thrombomodulin
JP4331891B2 (ja) 改良された血液凝固試験法
Cellai et al. Assessment of fibrinolytic activity by measuring the lysis time of a tissue factor-induced clot: a feasibility evaluation
RU2835822C9 (ru) Способ определения антикоагулянтного потенциала плазмы крови для диагностики предтромботических состояний
RU2835822C1 (ru) Способ определения антикоагулянтного потенциала плазмы крови для диагностики предтромботических состояний
AU748476B2 (en) Improved blood coagulation test